Comparison between mesothelin and fibulin-3 detection in pleural malignant mesothelioma (MPM) patients

被引：0
|
作者：
Pinelli, Valentina
Fini, Donatella
Battolla, Enrico
Ferro, Paola
Franceschini, Maria Cristiana
Fontana, Vincenzo
Pistillo, Maria Pia
Roncella, Silvio
Canessa, Pier Aldo
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2016年 / 48卷
关键词：
Mesothelioma; Pleura; Biomarkers;
D O I：
10.1183/13993003.congress-2016.PA5075
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA5075
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Determination of Mesothelin Levels in Pleural Effusion Does Not Help Predict Survival of Patients With Malignant Pleural Mesothelioma
    Fontana, Vincenzo
    Pistillo, Maria Pia
    Vigani, Antonella
    Canessa, Pier Aldo
    Berisso, Giovanni
    Giannoni, Ugo
    Ferro, Paola
    Franceschini, Maria Cristiana
    Carosio, Roberta
    Tonarelli, Marika
    Rossi, Cristiana
    Dessanti, Paolo
    Roncella, Silvio
    ANTICANCER RESEARCH, 2019, 39 (09) : 5219 - 5223
  • [22] Phase II study of pemetrexed in combination with carboplatin in patients with malignant pleural mesothelioma (MPM)
    Castagneto, B.
    Botta, M.
    Aitini, E.
    Spigno, F.
    Degiovanni, D.
    Alabiso, O.
    Serra, M.
    Muzio, A.
    Carbone, R.
    Buosi, R.
    Galbusera, V.
    Piccolini, E.
    Giaretto, L.
    Rebella, L.
    Mencoboni, M.
    ANNALS OF ONCOLOGY, 2008, 19 (02) : 370 - 373
  • [23] The extracellular matrix protein fibulin-3/EFEMP1 promotes pleural mesothelioma growth by activation of PI3K/Akt signaling
    Roshini, Arivazhagan
    Goparaju, Chandra
    Kundu, Somanath
    Nandhu, Mohan S.
    Longo, Sharon L.
    Longo, John A.
    Chou, Joan
    Middleton, Frank A.
    Pass, Harvey I.
    Viapiano, Mariano S.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [24] Mesothelin, Calretinin, and Megakaryocyte Potentiating Factor as Biomarkers of Malignant Pleural Mesothelioma
    Jimenez-Ramirez, Carmina
    Casjens, Swaantje
    Arturo Juarez-Perez, Cuauhtemoc
    Raiko, Irina
    Del Razo, Luz M.
    Taeger, Dirk
    Calderon-Aranda, Emma S.
    Rihs, Hans-Peter
    Concepcion Acosta-Saavedra, Leonor
    Weber, Daniel Gilbert
    Cabello-Lopez, Alejandro
    Pesch, Beate
    Dolores Ochoa-Vazquez, Maria
    Burek, Katarzyna
    Torre-Bouscoulet, Luis
    Rogelio Perez-Padilla, Jose
    Marco Garcia-Bazan, Erik
    Bruening, Thomas
    Johnen, Georg
    Aguilar-Madrid, Guadalupe
    LUNG, 2019, 197 (05) : 641 - 649
  • [25] Mesothelin, Calretinin, and Megakaryocyte Potentiating Factor as Biomarkers of Malignant Pleural Mesothelioma
    Carmina Jiménez-Ramírez
    Swaantje Casjens
    Cuauhtémoc Arturo Juárez-Pérez
    Irina Raiko
    Luz M. Del Razo
    Dirk Taeger
    Emma S. Calderón-Aranda
    Hans-Peter Rihs
    Leonor Concepción Acosta-Saavedra
    Daniel Gilbert Weber
    Alejandro Cabello-López
    Beate Pesch
    María Dolores Ochoa-Vázquez
    Katarzyna Burek
    Luis Torre-Bouscoulet
    José Rogelio Pérez-Padilla
    Erik Marco García-Bazan
    Thomas Brüning
    Georg Johnen
    Guadalupe Aguilar-Madrid
    Lung, 2019, 197 : 641 - 649
  • [26] Targetable Cancer-Associated Antigens for Immunotherapy in Malignant Pleural Mesothelioma (MPM) - Mesothelin, CA125 and WT-1
    Ujiie, Hideki
    Eguchi, Takashi
    Mayor, Marissa
    Kadota, Kyuichi
    Travis, William D.
    Jones, David R.
    Sadelain, Michel
    Adusumilli, Prasad S.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S755 - S756
  • [27] LACK OF RESPONSE TO CHEMOTHERAPY FOR PREVIOUSLY TREATED MALIGNANT PLEURAL MESOTHELIOMA (MPM)
    Zauderer, Marjorie G.
    Kass, Samantha L.
    Sima, Camelia S.
    Ginsberg, Michelle S.
    Krug, Lee M.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S638 - S639
  • [28] A Phase II Trial of Nintedanib in Recurrent Malignant Pleural Mesothelioma (MPM)
    Wozniak, A.
    Schneider, B.
    Kalemkerian, G.
    Daly, R.
    Chen, W.
    Ventimiglia, J.
    Nagasaka, M.
    Zauderer, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S343 - S343
  • [29] Healthcare Professional Perceptions of Chemotherapy in Treatment of Malignant Pleural Mesothelioma (MPM)
    Kao, Steven
    Dhillon, Haryana
    Warby, Anne
    Vardy, Janette
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S629 - S629
  • [30] Pilot Window-Of-Opportunity Study of Pembrolizumab in Patients with Resectable Malignant Pleural Mesothelioma (MPM)
    Kindler, Hedy
    Ferguson, Mark
    Tan, Yi-Huang
    Rose, Buerkley
    Ahmad, Mehwish
    Armato, Samuel
    Straus, Christopher
    Karrison, Theodore
    Seiwert, Tanguy
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1089 - S1089
12345